California eyes making girls flag football a school sport
Elsa Morin gripped the football and launched a perfect spiral. Then the 17-year-old dodged in and out of cones and yanked the flag hanging from another girl’s belt for a key defensive play.
Elsa Morin gripped the football and launched a perfect spiral. Then the 17-year-old dodged in and out of cones and yanked the flag hanging from another girl’s belt for a key defensive play.
An attorney for Leavenworth County said he does not know how much money the county will receive from the state as a result of settlements related to opioid drug litigation. Commissioner Doug Smith inquired about the funding Wednesday during a meeting of the County Commission.
area tree services participated in the Saluting Branches event Wednesday at Leavenworth National Cemetery. The annual one-day event was held at about 100 national cemeteries across the country. The event is an opportunity for arborists to donate their time and expertise by meeting some of the tree care needs of local veterans’ cemeteries.
Dr. Scott Darling, a new skin and vein doctor in Leavenworth, has opened a new location in Cushing Medical Plaza.
Arare foggy and drippy day in Colorado Springs has allowed me to remain indoors and reflect on my current visit. Visibility as I write is less than 100 yards.
Associated Press Hurricane Ian’s most damaging winds began hitting Florida’s southwest coast Wednesday, lashing the state with heavy rain and pushing a devastating storm surge after strengthening to the threshold of the most dangerous Category 5 status. Fueled by warm waters in the Gulf of Mexico, Ian grew to a catastrophic Category 4 hurricane overnight with top winds of 155 mph, according to the National Hurricane Center.
Wire reports A Kansas prosecutor has indicated that he intends to try a woman for the third time in the killings of her ex-husband and his girlfriend two decades ago. Dana Chandler is accused of killing 47-yearold Mike Sisco and his fiancee, 53-year-old Karen Harkness, in 2002 in Topeka.
Shares of Biogen and other drugmakers researching Alzheimer’s disease soared early Wednesday after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease’s progress in a latestage study. Eisai announced results late Tuesday from a global study of nearly 1,800 people with early- stage Alzheimer’s. The drugmaker said early results showed that its treatment, lecanemab, reduced patient clinical decline by 27% when compared to a placebo or fake drug after 18 months of the infused treatment. Patients were monitored using a scale that measures how they do in areas like memory, judgement, problem solving and personal care.